PASQUINI, BENEDETTA
 Distribuzione geografica
Continente #
NA - Nord America 6.282
EU - Europa 4.505
AS - Asia 4.207
SA - Sud America 637
Continente sconosciuto - Info sul continente non disponibili 211
AF - Africa 126
OC - Oceania 60
Totale 16.028
Nazione #
US - Stati Uniti d'America 6.118
IT - Italia 1.530
RU - Federazione Russa 1.393
CN - Cina 983
SG - Singapore 900
BR - Brasile 508
HK - Hong Kong 488
IN - India 360
VN - Vietnam 359
KR - Corea 352
IE - Irlanda 347
SE - Svezia 250
FR - Francia 199
PL - Polonia 150
DE - Germania 129
BD - Bangladesh 123
JP - Giappone 123
FI - Finlandia 115
GB - Regno Unito 111
JO - Giordania 99
TR - Turchia 99
CA - Canada 87
ES - Italia 61
AU - Australia 59
IR - Iran 52
NL - Olanda 50
ID - Indonesia 46
IQ - Iraq 46
AR - Argentina 43
MX - Messico 36
EG - Egitto 31
TW - Taiwan 31
BE - Belgio 30
EC - Ecuador 29
TH - Thailandia 27
ZA - Sudafrica 26
RS - Serbia 24
PK - Pakistan 22
UA - Ucraina 19
CI - Costa d'Avorio 18
CO - Colombia 16
MY - Malesia 15
SA - Arabia Saudita 15
DK - Danimarca 14
NG - Nigeria 14
VE - Venezuela 14
CU - Cuba 11
PH - Filippine 11
AE - Emirati Arabi Uniti 10
DZ - Algeria 10
CH - Svizzera 9
CL - Cile 9
MA - Marocco 9
PE - Perù 8
UZ - Uzbekistan 8
CZ - Repubblica Ceca 7
KZ - Kazakistan 7
MK - Macedonia 7
PT - Portogallo 7
RO - Romania 7
IL - Israele 6
NO - Norvegia 6
AT - Austria 5
PR - Porto Rico 5
PY - Paraguay 5
UY - Uruguay 5
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
CR - Costa Rica 4
HR - Croazia 4
HU - Ungheria 4
JM - Giamaica 4
LT - Lituania 4
NP - Nepal 4
PA - Panama 4
TN - Tunisia 4
BJ - Benin 3
GR - Grecia 3
GT - Guatemala 3
KG - Kirghizistan 3
YE - Yemen 3
BH - Bahrain 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GH - Ghana 2
KE - Kenya 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
MD - Moldavia 2
MT - Malta 2
MW - Malawi 2
QA - Qatar 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
BB - Barbados 1
CW - ???statistics.table.value.countryCode.CW??? 1
Totale 15.804
Città #
Santa Clara 1.294
Ashburn 717
Singapore 681
Hong Kong 405
Dublin 340
Fairfield 333
Chandler 326
Seoul 258
Beijing 234
Milan 234
Florence 229
San Jose 220
Dallas 163
Council Bluffs 155
Woodbridge 153
Warsaw 141
Hefei 140
Cambridge 137
The Dalles 134
Seattle 133
Wilmington 125
Ho Chi Minh City 118
New York 112
Ann Arbor 108
Houston 107
Princeton 105
Rome 98
Hanoi 94
Tokyo 92
Los Angeles 91
Lauterbourg 87
Mumbai 62
Paris 61
Buffalo 56
São Paulo 56
Boston 52
Melbourne 52
Shanghai 52
Boardman 50
Lawrence 50
Medford 49
Altamura 47
Clifton 47
Kent 45
Moscow 42
Bengaluru 40
Helsinki 38
Hyderabad 36
Munich 35
Ahmedabad 34
Bologna 33
Rio de Janeiro 33
Dongjak-gu 30
Izmir 30
Guangzhou 29
Turin 28
San Diego 27
Naples 26
Istanbul 25
Toronto 24
Barcelona 22
Palermo 21
Redondo Beach 21
Belgrade 19
Abidjan 18
Da Nang 18
Figino 18
Frankfurt am Main 18
Haiphong 18
Tehran 18
Bari 17
Cairo 17
Jacksonville 17
Jinju 17
Mexico City 17
Quito 17
Brussels 16
Chennai 16
Genoa 16
Bangkok 15
Chicago 15
Pune 15
Surat 15
Turku 15
Vadodara 15
Abuja 14
Brooklyn 14
Phoenix 14
Basingstoke 13
Copenhagen 13
Falls Church 13
Hillsboro 13
Orem 13
Taichung 13
Trieste 13
Ankara 12
Basra 12
Catania 12
Montreal 12
Tianjin 12
Totale 9.377
Nome #
New trends in Quality Control: new compendial and ICH guidelines outlining Quality by Design (QbD) principles 536
Estrazione in fase solida in linea (On-line SPE) accoppiata a determinazione LC-MS/MS di alchilfenoli polietossilati e dei loro metaboliti carbossilici e fenolici in acque di scarico 444
Sviluppo di metodologie analitiche di tipo elettroforetico e loro impiego in problematiche farmaceutiche 399
Development of analytical methods for quality control of therapeutic proteins using Quality by Design principles: the Infliximab case study 332
Synthesis of nanoparticle-decorated biodegradable membranes for use in electro-membrane extraction techniques 257
Risk-based approach for method development: quality by design strategy in the analysis of nintedanib and its related impurities by LC-MS 253
Combined approach using capillary electrophoresis, NMR and molecular modeling for ambrisentan related substances analysis: Investigation of intermolecular affinities, complexation and separation mechanism 234
Development of separative methods for harmonizing Quality Control of Monoclonal Antibodies by using an Analytical Quality by Design approach 233
Assessment of skin microvascular response through pregnancy using laser speckle contrast imaging 229
Analytical Quality by Design in pharmaceutical quality assurance: Development of a capillary electrophoresis method for the analysis of zolmitriptan and its impurities 227
A real‐life pediatric experience of Crohn's disease exclusion diet at disease onset and in refractory patients 218
Combination of capillary electrophoresis, molecular modeling and NMR to study the enantioselective complexation of sulpiride with double cyclodextrin systems 215
A comprehensive strategy in the development of a cyclodextrin-modified microemulsion electrokinetic chromatographic method for the assay of diclofenac and its impurities: Mixture-process variable experiments and quality by design 213
Analytical quality by design in the development of a cyclodextrin-modified capillary electrophoresis method for the assay of metformin and its related substances 210
Quality by Design as a risk-based strategy in pharmaceutical analysis: Development of a liquid chromatography-tandem mass spectrometry method for the determination of nintedanib and its impurities 202
Quality by Design and Analytical Quality by Design for Pharmaceutical Development 200
Quality Control of recombinant proteins: the case of infliximab 200
Analytical quality by design: Development and control strategy for a LC method to evaluate the cannabinoids content in cannabis olive oil extracts 196
Chiral capillary zone electrophoresis in enantioseparation and analysis of cinacalcet impurities: Use of Quality by Design principles in method development 195
An integrated quality by design and mixture-process variable approach in the development of a capillary electrophoresis method for the analysis of almotriptan and its impurities 193
Analytical quality by design in the development of a solvent-modified micellar electrokinetic chromatography method for the determination of sitagliptin and its related compounds 192
Quality by design approach in the development of an ultra-high-performance liquid chromatography method for Bexsero meningococcal group B vaccine 187
Quality by Design for the optimization of a fast HPLC-DAD method for the analysis of cannabinoids in magistral preparations 186
Development of a capillary electrophoresis method for the assay of ramipril and its impurities: An issue of cis-trans isomerization 184
Quality by design in the optimization of a nanosystem-ethosomal formulation for topical treatment of vitiligo 184
Enantioseparation and impurity determination of ambrisentan using cyclodextrin-modified micellar electrokinetic chromatography: Visualizing the design space within quality by design framework 184
Evaluation of the separation mechanism of electrokinetic chromatography with a microemulsion and cyclodextrins using NMR and molecular modeling 181
Analytical quality by design and design of experiments: a useless complication or an opportunity for separation sciences? 180
Cyclodextrin- and solvent-modified micellar electrokinetic chromatography for the determination of captopril, hydrochlorothiazide and their impurities: A Quality by Design approach 177
Exploring the intermolecular interactions acting in solvent-modified MEKC by Molecular Dynamics and NMR: The effect of n-butanol on the separation of diclofenac and its impurities 177
Analytical Quality by Design: development and control strategy for a RP-HPLC method implemented in routine to evaluate the cannabinoids content in cannabis olive oil extracts 174
Development and optimization by Quality by Design strategies of frovatriptan orally disintegrating tablets for migraine management 172
Microemulsion electrokinetic chromatography: an application for the simultaneous determination of suspected fragrance allergens in rinse-off products 171
Combination of capillary electrophoresis, Quality by Design, NMR and molecular modeling for impurity profiling: definition of the design space and investigation of intermolecular affinities, complexation and separation mechanisms 169
Quality by Design per l’ottimizzazione dell’analisi UHPLC di polifenoli selezionati nel Diospyros Kaki 168
Exploring the diagnostic potential of chemometric fingerprinting from FFF-sorted biological samples to track and detect exosomal population in cancer patients’ serum 165
An integrated Quality by Design approach towards the Design Space definition of a capillary electrophoresis method for the analysis of triptans 165
Quality by Design and capillary electrophoresis in the development of thymoquinone-loaded vesicular systems for topical treatment of vitiligo 165
Endometriosis and the diagnosis of different forms of migraine: an association with dysmenorrhoea 164
Quality by Design: sviluppo di un metodo CD-CZE per la determinazione della purezza enantiomerica della levosulpiride e studi sul meccanismo alla base della separazione 164
Fully automated on-line solid phase extraction coupled to liquid chromatography–tandem mass spectrometry for the simultaneous analysis of alkylphenol polyethoxylates and their carboxylic and phenolic metabolites in wastewater samples 164
Human fecal short chain fatty acids determination by SPME-GC-MS: disease monitoring by a chemometric approach in pediatric Crohn’s Disease 163
Chiral cyclodextrin-modified micellar electrokinetic chromatography and chemometric techniques for green tea samples origin discrimination 163
Quality by design compliant strategy for the development of a liquid-chromatography-tandem mass spectrometry method for the determination of selected polyphenols in Diospyros kaki 163
Schwann cell C5aR1 co-opts inflammasome NLRP1 to sustain pain in a mouse model of endometriosis 162
Fast analysis of glibenclamide and its impurities: quality by design framework in capillary electrophoresis method development 160
Quality by Design approach in the development of an UHPLC method for the analysis of selected polyphenols in Diospyros Kaki 159
Electrodeposition of aluminium from ionic liquids: corrosion behavior and deposition parameters influence 158
Analytical Quality by Design approach in the development of a CE method for the simultaneous determination of zolmitriptan and its impurities 156
Optimisation of a microemulsion EKC method in reverse polarity for the analysis of ramipril and its related substances 155
Chiral analysis of theanine and catechin in characterization of green tea by cyclodextrin-modified micellar electrokinetic chromatography and high performance liquid chromatography 147
Multivariate optimization of human fecal fatty acids determination by HS-SPME-GC-MS 145
Geographical characterisation of honeys according to their mineral content and antioxidant activity using a chemometric approach 145
Quality by design in the chiral separation strategy for the determination of enantiomeric impurities: Development of a capillary electrophoresis method based on dual cyclodextrin systems for the analysis of levosulpiride 144
Impurity profiling by capillary electrophoresis: definition of the design space within quality by design approach and investigation of separation mechanism and selectivity 144
The successful binomium of multivariate strategies and electrophoresis for the Quality by Design separation of a class of drugs: the case of triptans 143
Insights into EKC with microemulsions and cyclodextrins by means of NMR and molecular modeling: clemastine case study 142
Development of orally disintegrating tablets (ODTs) of frovatriptan by use of Quality by Design strategies 142
Recent applications of the derivatization techniques in capillary electrophoresis 141
Quality by Design framework in the development of a capillary electrophoresis method for the enantioseparation and impurity determination of cinacalcet hydrochloride 137
Effect of cosurfactant on separation selectivity in solvent-modified MEKC: the diclofenac case 135
Classification of green teas from different geographical origins based on micellar electrokinetic chromatography and chemometric techniques 134
Modern trends in drug analysis: visualizing design space in the quality control of pharmaceuticals by capillary electrophoresis 132
Combining excitation-emission fluorescence spectroscopy, parallel factor analysis, cyclodextrin-modified micellar electrokinetic chromatography and partial least squares class-modelling for green tea characterization 132
Quality by Design approach in the development of a solvent-modified micellar electrokinetic chromatography method: Finding the design space for the determination of amitriptyline and its impurities 132
Enantioseparation and impurity determination of cinacalcet using solvent modified capillary zone electrophoresis and Quality by Design: study of the complexation with cyclodextrins by molecular modeling and NMR 131
Evaluation of the separation mechanism in a dual-CD microemulsion system for capillary electrophoresis analysis 130
Analytical Quality by Design: from advanced Quality Control techniques to a Citizen Science perspective 128
Quality by Design approach: why to use it? 128
Quality by Design meets combination drugs: simultaneous determination of captopril, hydrochlorothiazide and their impurities by capillary electrophoresis 126
Control strategy applied to a LC-DAD quality control method as part of the analytical quality by design approach: one year of routine use 125
Characterization and chemical profiling of green tea samples using capillary electrophoresis combined with chemometrics 125
Quality by Design and Mixture-Process Variable approach in the development of a cyclodextrin-MEEKC method for the assay of diclofenac and its impurities 122
Quality by Design in analisi farmaceutica 120
Optimization of hydrolysis conditions of amino acid analysis for UHPLC-UV antigens content determination: Bexsero vaccine a case study 116
Development of a CE method for assaying ramipril and its impurities: an issue of cis-trans interconversion 115
Classification models in newborn screening for metabolic diseases by LC-MS/MS 113
Design Space identification of hydrolysis conditions for amino acid analysis applying Quality by Design approach 112
Quality by Design strategy as a risk-based framework for the optimization of fast and selective chromatographic methods for the analysis of bioactive mixtures: potentiality and critical issues 111
Mixture-Process variable approach to optimize a microemulsion electrokinetic chromatography method for the quality control of an integrator based on Coenzyme Q10. 110
Quality by Design approach towards the Design Space definition in the development of a solvent-modified electrokinetic chromatography method 109
Quality by design-driven optimization of dried blood spot extraction for a bioanalytical LC-MS method 108
Experimental design and capillary electrophoresis in the development of cyclodextrin-based hydrogels for oral administration of oxaprozin 104
Quality by Design, NMR and Molecular Modeling for the investigation of intermolecular affinities and separation mechanisms in capillary electrophoretic methods for assaying drugs and their impurities 102
Shaping Quality Control of Biopharmaceuticals with Analytical Quality by Design 101
Quality by Design: an opportunity for the pharmaceutical industry 101
Quality by Design and capillary electrophoresis for developing orally disintegrating tablets containing frovatriptan 100
Fluorescence spectroscopy and chemometric techniques for geographical discrimination of green tea samples 99
Innovative capillary electrophoresis method development for the determination of almotriptan and its impurities: Quality by Design approach 99
Mixture-process approach to optimize a microemulsion electrokinetic chromatography method for the quality control of an integrator based on coenzyme q10 95
Fast analysis of glibenclamide and its related substances by capillary electrophoresis 94
Development of a dual cyclodextrin system-capillary electrophoresis method for the determination of the enantiomeric purity of levosulpiride 85
Quality by Design for capillary electrophoresis method development: analysis of metformin and its impurities 83
Pharmaceutical Quality by Design: development of a capillary electrophoresis method for the assay of amitriptyline and its related substances 78
Geographical characterisation of honeys by a chemometric approach: a comparative study among classification models 75
Systematic development and optimization of a cIEF method for the charge variants analysis of basic monoclonal antibodies using the Analytical Quality by Design strategy 70
Evaluation of the inclusion complex formation of levosulpiride and cyclodextrins by capillary electrophoresis, molecular modeling and NMR 67
The Versatility of Analytical Quality by Design: Empowering Advanced Methods and Citizen Science Tools 65
A Design of Experiments and Risk Management‑Driven Analytical Platform for Charge Variant Analysis of Therapeutic Antibodies by Imaged Capillary Isoelectric Focusing 55
Analytical quality by design in the development of a paper-based microfluidic device for iron (II) determination as an impurity in iron (III) pharmaceuticals 44
Totale 15.939
Categoria #
all - tutte 41.547
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.547


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022423 0 65 38 13 15 12 9 25 15 10 45 176
2022/20231.417 155 207 57 89 101 224 193 73 199 30 55 34
2023/2024970 41 52 133 72 64 128 73 184 24 61 90 48
2024/20254.514 214 447 328 710 1.201 635 72 149 177 176 197 208
2025/20266.105 507 742 620 679 630 255 620 305 404 327 249 767
2026/2027472 252 220 0 0 0 0 0 0 0 0 0 0
Totale 16.028